Novo Holdings to sell 7.8% stake in UK's Convatec, bookrunner says

Core Viewpoint - Novo Holdings plans to sell 155 million shares, representing approximately 7.8% of its stake in Convatec Group, a British medical products manufacturer [1] Company Summary - Novo Holdings is the controlling entity of Novo Nordisk, a company focused on obesity treatments [1] - Convatec Group specializes in medical products, indicating a strategic interest in the healthcare sector by Novo Holdings [1] Transaction Details - The share sale involves 155 million shares of Convatec Group, which is a significant portion of Novo Holdings' investment [1] - The transaction is being managed by a bookrunner, highlighting the structured approach to the sale [1]